Polypharmacy and Incontinence;Polypharmazie und Inkontinenz

Zeitschrift fur Gerontologie und Geriatrie

Volumn 45, Issue 6, 2012, Pages 464-467

  Talasz, Helena ^a   Lechleitner, M ^a  

^a Hochzirl Hospital   (Austria)

Author keywords

Adverse effects; Anticholinergics; Geriatrics; Incontinence; Polyuria

Indexed keywords

AGED; ARTICLE; DRUG INTERACTION; DRUG TOXICITY; FEMALE; HUMAN; INCIDENCE; MALE; POLYPHARMACY; RISK ASSESSMENT; RISK FACTOR; URINE INCONTINENCE;

AGED; AGED, 80 AND OVER; DRUG INTERACTIONS; DRUG TOXICITY; FEMALE; HUMANS; INCIDENCE; MALE; POLYPHARMACY; RISK ASSESSMENT; RISK FACTORS; URINARY INCONTINENCE;

EID: 84865746482     PISSN: 09486704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00391-012-0358-7     Document Type: Article

References (27)

1. Asplund R, Aberg H (1991) Diurnal variation in the levels of antidiuretic hormone in the elderly. J Intern Med 229(2):131-134
2. Beers MH, Ouslander JG, Rollingher I et al (1991) Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 151(9):1825-1832
3. Boudreau DM, Yu O, Gray SL et al (2009) Concomitant use of cholinesterase inhibitors and anticholinergics: prevalence and outcomes. J Am Geriatr Soc 57:1238-1244
4. Callaway E, Halliday R, Naylor H (1992) Cholinergic activity and constraints on information processing. Biol Psychol 33:1-22
5. Chapple CR, Khullar V, Gabriel Z et al (2008) The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol 54:543-562
6. Cigolle CT, Langa KM, Kabeto MU et al (2007) Geriatric conditions and disability: the Health and Retirement Study. Ann Intern Med 147:156-164
7. DuBeau CE, Kuchel GA, Johnson T et al (2009) Incontinence in the frail elderly. In: Abrams P, Cardozo L, Khoury S, Wein A (eds) 4th International Consultation on Incontinence. Recommendations of the International Scientific Committee: Evaluation and Treatment of Urinary Incontinence, Pelvic Organ Prolapse and Faecal Incontinence. 4th ed. Health Publication Ltd, Paris, pp 961-1024
8. Gallagher P, Ryan C, Byrne S et al (2008) STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 46(2):72-83
9. Gill SS, Mamdani M, Naglie G et al (2005) A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs. Arch Intern Med 165:808
10. Hogan DB (1997) Revisiting the O complex: urinary incontinence, delirium and polypharmacy in elderly patients. CMAJ 157(8):1071-1077
11. Holroyd-Leduc JM, Mehta KM, Covinsky KE (2004) Urinary incontinence and its association with death, nursing home admission, and functional decline. J Am Geriatr Soc 52:712-718
12. Holt S, Schmiedl S, Thürmann PA (2010) Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Ärztebl 107:543-551
13. Kessler TM, Bachmann LM, Minder C et al (2011) Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach. PLoS ONE 6(2):e16718. doi: 10.1371/journal.pone.0016718
14. Laroche ML, Charmes JP, Merle L (2007) Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 63:725-731
15. Madhuvrata P, Cody JD, Ellis G et al (2012) Which anticholinergic drug for overactive bladder symptoms in adults. Cochrane Database Syst Rev 1:CD005429
16. Milsom I, Altman D, Lapitan MC et al (2009) Epidemiology of urinary and faecal incontinence and pelvic organ prolapse. In: Abrams P, Cardozo L, Khoury S, Wein A (eds) 4th International Consultation on Incontinence. Recommendations of the International Scientific Committee: Evaluation and Treatment of Urinary Incontinence, Pelvic Organ Prolapse and Faecal Incontinence. 4th ed. Health Publication Ltd., Paris, France, pp 35-111
17. Modi A, Weiner M, Craig BA et al (2009) Concomitant use of anticholinergics with acetylcholinesterase inhibitors in Medicaid recipients with dementia and residing in nursing homes. J Am Geriatr Soc 57:1238
18. Novara G, Galfano A, Secco S et al (2008) A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur Urol 54(4):740-764
19. Österreichisches Basisassessment. http://www.geriatrie-online.at. Accessed 12 June 2012
20. Ouslander JG, Johnson TM (1998) Incontinence. In: Hazzard WR, Blass JP, Ettinger WH et al (eds) Principles of Geriatric Medicine and Gerontology. 4th Ed. McGraw-Hill, New York, pp 1595-1613
21. Ouslander JG et al (1998) Arginine vasopressin levels in nursing home residents with nighttime urinary incontinence. J Am Geriatr Soc 46:1274-1279
22. Mann E, Böhmdorfer B, Frühwald T et al (2012) Potentially inappropriate medication in geriatric patients: the Austrian consensus panel list. Wien Klin Wochenschr 124(5-6):160-169
23. Robinson D, Cardozo L (2012) Antimuscarinic drugs to treat overactive bladder. BMJ 344:e2130. doi:10.1136/bmj.e2130
24. The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) AGS updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 60(4):616-631
25. Kerrebroeck P van et al (2002) The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:179-183
26. Weiss JP, Blaivas JG, Bliwise DL et al (2011) The evaluation and treatment of nocturia: a consensus statement. BJU Int 108:6-21
27. Woodford H, George J (2007) NICE guidelines on urinary incontinence in women. Age Ageing 36:349-350